Facebook
Twitter
LinkedIn
ForwardPresidential Plenary: The Future is Here
This plenary session is designed to engage learners in a discussion of the "why" and "how" pertaining to the roles of clinical practice guidelines, quality, and technological advancement in health care moving forward. Its speakers are lectureship recipients as follows:
| Lectureship | Speaker | Title |
|---|---|---|
| AAAAI Foundation and Phil and Barbara Lieberman and Friends Lectureship: Investing Together in Our Future | Jay Portnoy, MD FAAAAI | The Promise of Telemedicine as an Emerging and Disruptive Influence in Healthcare |
| AAAAI Foundation and Bettina C. Hilman, MD Lectureship | Holger Schunemann, MD MSc PhD | The Future of Clinical Practice Guidelines: Their Promise for Optimizing Healthcare Decision Making and Improving Patient-Centered Healthcare Outcomes |
| AAAAI Foundation and Louis M. Mendelson, MD FAAAAI Lectureship: Investing Together in Our Future | John Oppenheimer, MD FAAAAI | Will the Promise of Improved Patient-Centered Healthcare Outcomes Be Achieved via our Future Transition to Value-Based Reimbursement? |
Target Audience
- A/I physicians
- A/I fellows-in-training
- A/I nurses, nurse practitioners and physician assistants
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the utility of telemedicine for remotely diagnosing, monitoring, and treating patients with allergic/immunologic disorders
- Relate the future impact of clinical practice guidelines for optimizing health care decision making and improving health care outcomes for patients with allergic/immunologic disorders
- Discuss the transition to value-based reimbursement currently in progress, that will increasingly incentivize allergy/immunology providers to deliver care focused on quality metrics and patient satisfaction, and discourage services that are redundant or of low value
Faculty
Jay Portnoy, MD FAAAAI
Children's Mercy Hospital, Kansas City, MO
Relevant relationships: None
Holger Schunemann, MD MSc PhD
McMaster University Health Sciences Center, West Hamilton, ON Canada
Relevant relationships: None
John Oppenheimer, MD FAAAAI
Pulmonary and Allergy Associates, Morristown, NJ
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on April 30, 2022. Requests to claim credit on or after May 1, 2022 will be denied.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Questions
Activity-related questions should be directed to cme@aaaai.org.
Available Credit
- 1.50 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.50 CMECME credit.